Seventh-seeded Scotch Plains-Fanwood scored eight runs in the fourth inning to erase an early deficit and defeat sixth-seeded Bridgewater-Raritan, 10-5, in the semifinal round of the North 2, Group ...

Lucas Nunez struck out two batters over four innings and Hightstown erupted for eight runs in the fourth inning to defeat Monroe 10-2 in the quarterfinal round of the Central, Group 4 Tournament in ...

MADISON, Wis. (WBAY) - Gov. Tony Evers and the Wisconsin Department of Workforce Development announced applications are now open to give workers job training in advanced manufacturing or artificial ...

The above video is our WITN+ livestream and may not reflect the content in this story. WILLIAMSTON, N.C. (WITN) - Martin Community College is adding a new practical nursing program starting in January ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) ("Oklo," or "the Company"), an advanced nuclear technology company, today announced that Oklo has been selected by the U.S. Department of ...

CALYPSO — Trailing 9-4 to the Manteo Redskins after the top of the sixth inning, it seemed like North Duplin’s season was over. However, the Rebels never lost belief, and they rallied off an ...

The Republican nominee for Georgia’s next governor will be settled in a runoff election next month in the race to succeed term-limited GOP Gov. Brian Kemp. Lt. Gov. Burt Jones and billionaire health ...

LUBBOCK, Texas (KCBD) - The Red Raiders took on the Ole Miss Rebels in the Lubbock Regional Final Sunday afternoon, looking to punch their way into the NCAA Super Regional. Scoreless in the second ...

Trump to Israel: Let the al-Qaeda Guy Handle Hezbollah An Epochal Mass Casualty Attack Targeting ‘Capitalist Elites’ Thwarted Has Trump Promised Iran That He’ll Stop Israel from Fighting Hezbollah?

MONTREAL — It might have come a day later than scheduled, but on Tuesday night, in a decisive Game 5 of the PWHL semifinals between the Montreal Victoire and Minnesota Frost, the inevitability of ...

The first‑in‑class antibody program is designed to selectively target pathogenic cells, with the potential to deliver deeper and more durable disease control than current therapies. The agreement ...

Dr. Martine Rothblatt framed the quarter around two Phase III programs, saying, "We just proved beyond a shadow of a doubt with a p-value of less than 0.0001 that we have 2 different therapeutics in 2 ...